1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Immunotherapy Drugs Revenue
• 1.4 Market by Type
  • 1.4.1 Global Immunotherapy Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Adult Vaccines
  • 1.4.4 Checkpoint Inhibitors
  • 1.4.5 Interferons Alpha & Beta
  • 1.4.6 Interleukins
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Immunotherapy Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Cancer
  • 1.5.3 Autoimmune & Inflammatory Diseases
  • 1.5.4 Infectious Diseases
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Immunotherapy Drugs Market Perspective (2015-2026)
• 2.2 Global Immunotherapy Drugs Growth Trends by Regions
  • 2.2.1 Immunotherapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Immunotherapy Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Immunotherapy Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Immunotherapy Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Immunotherapy Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Immunotherapy Drugs Players by Market Size
  • 3.1.1 Global Top Immunotherapy Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Immunotherapy Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Immunotherapy Drugs Market Concentration Ratio
  • 3.2.1 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Immunotherapy Drugs Revenue in 2019
• 3.3 Immunotherapy Drugs Key Players Head office and Area Served
• 3.4 Key Players Immunotherapy Drugs Product Solution and Service
• 3.5 Date of Enter into Immunotherapy Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Immunotherapy Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Immunotherapy Drugs Market Size by Application (2015-2020)
• 5.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Immunotherapy Drugs Market Size (2015-2020)
• 6.2 Immunotherapy Drugs Key Players in North America (2019-2020)
• 6.3 North America Immunotherapy Drugs Market Size by Type (2015-2020)
• 6.4 North America Immunotherapy Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Immunotherapy Drugs Market Size (2015-2020)
• 7.2 Immunotherapy Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Immunotherapy Drugs Market Size by Type (2015-2020)
• 7.4 Europe Immunotherapy Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Immunotherapy Drugs Market Size (2015-2020)
• 8.2 Immunotherapy Drugs Key Players in China (2019-2020)
• 8.3 China Immunotherapy Drugs Market Size by Type (2015-2020)
• 8.4 China Immunotherapy Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Immunotherapy Drugs Market Size (2015-2020)
• 9.2 Immunotherapy Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Immunotherapy Drugs Market Size by Type (2015-2020)
• 9.4 Japan Immunotherapy Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Immunotherapy Drugs Market Size (2015-2020)
• 10.2 Immunotherapy Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Immunotherapy Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Immunotherapy Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Immunotherapy Drugs Market Size (2015-2020)
• 11.2 Immunotherapy Drugs Key Players in India (2019-2020)
• 11.3 India Immunotherapy Drugs Market Size by Type (2015-2020)
• 11.4 India Immunotherapy Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Immunotherapy Drugs Market Size (2015-2020)
• 12.2 Immunotherapy Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Immunotherapy Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Immunotherapy Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche
  • 13.1.1 Roche Company Details
  • 13.1.2 Roche Business Overview
  • 13.1.3 Roche Immunotherapy Drugs Introduction
  • 13.1.4 Roche Revenue in Immunotherapy Drugs Business (2015-2020))
  • 13.1.5 Roche Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview
  • 13.2.3 Merck Immunotherapy Drugs Introduction
  • 13.2.4 Merck Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Novartis
  • 13.3.1 Novartis Company Details
  • 13.3.2 Novartis Business Overview
  • 13.3.3 Novartis Immunotherapy Drugs Introduction
  • 13.3.4 Novartis Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.3.5 Novartis Recent Development
• 13.4 Johnson & Johnson
  • 13.4.1 Johnson & Johnson Company Details
  • 13.4.2 Johnson & Johnson Business Overview
  • 13.4.3 Johnson & Johnson Immunotherapy Drugs Introduction
  • 13.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.4.5 Johnson & Johnson Recent Development
• 13.5 Glaxosmithkline
  • 13.5.1 Glaxosmithkline Company Details
  • 13.5.2 Glaxosmithkline Business Overview
  • 13.5.3 Glaxosmithkline Immunotherapy Drugs Introduction
  • 13.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.5.5 Glaxosmithkline Recent Development
• 13.6 Amgen
  • 13.6.1 Amgen Company Details
  • 13.6.2 Amgen Business Overview
  • 13.6.3 Amgen Immunotherapy Drugs Introduction
  • 13.6.4 Amgen Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.6.5 Amgen Recent Development
• 13.7 Abbvie
  • 13.7.1 Abbvie Company Details
  • 13.7.2 Abbvie Business Overview
  • 13.7.3 Abbvie Immunotherapy Drugs Introduction
  • 13.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.7.5 Abbvie Recent Development
• 13.8 Astrazeneca
  • 13.8.1 Astrazeneca Company Details
  • 13.8.2 Astrazeneca Business Overview
  • 13.8.3 Astrazeneca Immunotherapy Drugs Introduction
  • 13.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.8.5 Astrazeneca Recent Development
• 13.9 Bristol-Myers Squibb
  • 13.9.1 Bristol-Myers Squibb Company Details
  • 13.9.2 Bristol-Myers Squibb Business Overview
  • 13.9.3 Bristol-Myers Squibb Immunotherapy Drugs Introduction
  • 13.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.9.5 Bristol-Myers Squibb Recent Development
• 13.10 ELI Lilly
  • 13.10.1 ELI Lilly Company Details
  • 13.10.2 ELI Lilly Business Overview
  • 13.10.3 ELI Lilly Immunotherapy Drugs Introduction
  • 13.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2015-2020)
  • 13.10.5 ELI Lilly Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Immunotherapy Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunotherapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly

Market segment by Type, the product can be split into
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Market segment by Application, split into
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America